Opentrons Labworks Inc.
Opentrons Labworks, Inc., is a disruptive life science company leveraging its integrated lab platform to supercharge the pace of innovation in research and healthcare. Opentrons Labworks is the parent company to business units Opentrons Robotics and Neochromosome. Through Opentrons Robotics, thousands of institutions are automating R&D operations with flexible, easy-to-use liquid handling lab robots. Through Neochromosome, biopharma and biotech at large can benefit from our world-class genome-scale cell engineering solutions. Opentrons Robotics, a business unit of Opentrons Labworks, Inc., is the industry leader in flexible, user-friendly automation for life science labs. Our open-source ecosystem offers the scientific community the tools they need to automate experiments, share protocols and reproduce each other's results. Opentrons robots can be found in thousands of academic, biopharma, synthetic biology and clinical research labs in more than 40 countries.
Opentrons Labworks Inc.
Opentrons Labworks, Inc., is a disruptive life science company leveraging its integrated lab platform to supercharge the pace of innovation in research and healthcare. Opentrons Labworks is the parent company to business units Opentrons Robotics and Neochromosome. Through Opentrons Robotics, thousands of institutions are automating R&D operations with flexible, easy-to-use liquid handling lab robots. Through Neochromosome, biopharma and biotech at large can benefit from our world-class genome-scale cell engineering solutions. Opentrons Robotics, a business unit of Opentrons Labworks, Inc., is the industry leader in flexible, user-friendly automation for life science labs. Our open-source ecosystem offers the scientific community the tools they need to automate experiments, share protocols and reproduce each other's results. Opentrons robots can be found in thousands of academic, biopharma, synthetic biology and clinical research labs in more than 40 countries.
TL;DR
What they do: Develop accessible lab automation (liquid-handling robots and software) for research and healthcare (OT-2, Opentrons Flex, protocol tools)
Scale: More than 10,000 robotic systems deployed
Funding: Total disclosed funding ~$268.4M; $200M Series C led by SoftBank Vision Fund 2 (Sep 23, 2021)
Employees: Approximately 410
Founders: William (Will) Canine and Chiu Chau
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Lab automation and liquid-handling/pipetting robotics for life science R&D and related workflows (e.g., PCR, NGS, proteomics).
Industry
Biotechnology Research
Tech Stack
Funding Track Record
$200,000,000
Series C announced with participation from Khosla Ventures; press release lists additional investors including Sands Capital, Lerer Hippeau Ventures, SOSV, and Y Combinator.
Investor Signal
βLed by SoftBank Vision Fund 2 with participation from Khosla Ventures; additional investors named include Sands Capital, Lerer Hippeau Ventures, SOSV, and Y Combinator.β